Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase
Ruipeng Lei(University of Illinois Urbana-Champaign), Nicholas C. Wu(University of Illinois Urbana-Champaign), Christopher B. Brooke(University of Illinois Urbana-Champaign), Xinghong Dai(Case Western Reserve University), Ali H. Ellebedy(Washington University in St. Louis), Michael J. Scherm(Icahn School of Medicine at Mount Sinai), Zongjun Mou(Case Western Reserve University), Joel Rivera-Cardona(University of Illinois Urbana-Champaign), Rachel M. Presti(Johns Hopkins University), Aaron J. Schmitz(Washington University in St. Louis), Claire Graham(University of Illinois Urbana-Champaign), Wenhao O. Ouyang(University of Illinois Urbana-Champaign), Jackson S. Turner(Washington University in St. Louis), Chris Ka Pun Mok(Chinese University of Hong Kong), Timothy J.C. Tan(University of Illinois Urbana-Champaign), Florian Krammer(Semmelweis University), Yiquan Wang(University of Illinois Urbana-Champaign), Chuyun Teo(University of Illinois Urbana-Champaign), Wooseob Kim(Korea University), Huibin Lv(HKU-Pasteur Research Pole), Weiwen Liang(HKU-Pasteur Research Pole)
Cited by 46
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
|New England Journal of Medicine|2021|803
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713
Advances in the development of influenza virus vaccines
|Nature Reviews Drug Discovery|2015|597